Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Change in Acquisitions & Divestments (2016 - 2023)

Seres Therapeutics (MCRB) has disclosed Change in Acquisitions & Divestments for 9 consecutive years, with $11.8 million as the latest value for Q2 2023.

  • Quarterly Change in Acquisitions & Divestments fell 64.97% to $11.8 million in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $11.8 million through Mar 2024, down 89.08% year-over-year, with the annual reading at $23.0 million for FY2023, 83.64% down from the prior year.
  • Change in Acquisitions & Divestments hit $11.8 million in Q2 2023 for Seres Therapeutics, up from $11.2 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $54.8 million in Q2 2021 to a low of $2.5 million in Q3 2020.
  • Historically, Change in Acquisitions & Divestments has averaged $27.3 million across 5 years, with a median of $22.4 million in 2020.
  • Biggest five-year swings in Change in Acquisitions & Divestments: surged 1653.98% in 2021 and later crashed 74.52% in 2023.
  • Year by year, Change in Acquisitions & Divestments stood at $16.9 million in 2019, then rose by 1.68% to $17.2 million in 2020, then skyrocketed by 154.03% to $43.6 million in 2021, then plummeted by 50.81% to $21.5 million in 2022, then plummeted by 45.27% to $11.8 million in 2023.
  • Business Quant data shows Change in Acquisitions & Divestments for MCRB at $11.8 million in Q2 2023, $11.2 million in Q1 2023, and $21.5 million in Q4 2022.